PCR correction strategies for malaria drug trials: updates and clarifications
Authors:
- 1 January 2020
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 20 (1) , e20-e25
Abstract
No abstract availableKeywords
Funding Information
- Agence Nationale de la Recherche (ANR-17-CE13-0025-01)
This publication has 35 references indexed in Scilit:
- Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trialMalaria Journal, 2012
- Population genetic structure of Plasmodium falciparum across a region of diverse endemicity in West AfricaMalaria Journal, 2012
- Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and EliminationClinical Microbiology Reviews, 2011
- Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencingProceedings of the National Academy of Sciences, 2010
- The perils of PCR: can we accurately ‘correct’ antimalarial trials?Trends in Parasitology, 2010
- Gel versus capillary electrophoresis genotyping for categorizing treatment outcomes in two anti-malarial trials in UgandaMalaria Journal, 2010
- Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotypingMalaria Journal, 2009
- Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2)Malaria Journal, 2009
- A general SNP-based molecular barcode for Plasmodium falciparum identification and trackingMalaria Journal, 2008
- Impact of Transmission Intensity on the Accuracy of Genotyping To Distinguish Recrudescence from New Infection in Antimalarial Clinical TrialsAntimicrobial Agents and Chemotherapy, 2007